Abstract Hexavalent chromium (Cr(VI)) is present in the marine environment and is a known carcinogen and reproductive toxicant. Cr(VI) is the form of chromium that is well absorbed through the cell membrane. It is also the most prevalent form in seawater. We measured the total Cr levels in skin biopsies obtained from healthy free-ranging fin whales from the Gulf of Maine and found elevated levels relative to marine mammals in other parts of the world. The levels in fin whale biopsies ranged from 1.71 to 19.6 μg/g with an average level of 10.07 μg/g. We also measured the cytotoxicity and genotoxicity of Cr(VI) in fin whale skin cells. We found that particulate and soluble Cr(VI) are both cytotoxic and genotoxic to fin whale skin cells in a concentrationdependent manner. The concentration range used in our cell culture studies used environmentally relevant concentrations based on the biopsy measurements. These data suggest that Cr(VI) may be a concern for whales in the Gulf of Maine.
Introduction
Metals have emerged as a major concern for ocean health. Chromium is a naturally occurring metal commonly used as an anticorrosive and a dye in many paints. It gets into the environment through leaching from marine paints and through storm water and industrial runoff as well as deposition from air. The mean Cr level in the ocean is 0.3 μg/l [1] and the primary species in salt water is hexavalent chromium Cr(VI) [2, 3] . The primary source of environmental chromium is through industrial pollution to the atmosphere. One third of all atmospheric Cr released by anthropogenic sources is Cr(VI) [1] . More recently, we reported that Cr was a global marine pollutant with the high levels implicating Cr(VI) as the probable cause [4] .
Cr(VI) is a known human carcinogen with the ability to damage DNA and impair reproduction and development [5] [6] [7] [8] [9] [10] [11] [12] . The vast majority of Cr(VI) studies consider its impacts on human and laboratory animals or cell lines derived from them. By contrast, levels and impacts of Cr in marine species are poorly understood. In the ocean, marine mammals such as whales are the closest relatives to humans and effects in them reflect both threats to the animals as well as likely threats to humans.
We have been using marine mammals to study metal pollution, including Cr, in the ocean and its impacts on endangered species and populations as well as harbingers of threats to human health. Considering baleen whales, we found Cr levels of concern in the highly endangered Northern right whale (Eubalaena glacialis) off the coast of Maine [13] . In this study, Cr skin levels were found to be similar to skin levels of occupationally exposed workers with Cr-induced cancer. This concern appears to be regionally specific as a study of the Northern right whale's close cousin, the Southern right whale (Eubalaena australis), in Argentina, showed very low skin levels of Cr [14] . These two populations of whales are geographically distinct and do not intermix. Thus, they reflect different regions. These observations suggest a concern in the Gulf of Maine, though beyond these two reports, there are no apparent data of Cr levels in baleen whales from these regions.
The impact of Cr on whales is poorly understood. In baleen whales, the Northern right whale is the only species to be considered. The data show both particulate and soluble Cr(VI) compounds are cytotoxic and genotoxic to right whale skin, lung, and testes cells, indicating Cr is likely to be a carcinogen and reproductive hazard in whales [13, 15] . Data also indicate that Northern right whale cells are more resistant to the toxic effects of Cr(VI) than human cells [16] . However, because right whales are the only baleen whale species considered, it is unknown if they represent other whales or are particularly resistant.
Fin whales (Balaenoptera physalus) are considered endangered under the Endangered Species Act with the Western North Atlantic population only being 3,522 individuals [17] . Currently, there are no studies of Cr in fin whales. Accordingly, in this study, we measured Cr levels in fin whales from the Gulf of Maine and measured the cytotoxic and genotoxic effects of Cr(VI) in fin whale cells to further consider the hypothesis that Cr is a marine health concern.
Methods

Cell Culture
Fin whale skin fibroblasts were isolated from live animal skin biopsies. The cells were cultured in a 50:50 mixture of Dulbecco's minimal essential medium and Ham's F12 medium plus 15 % cosmic calf serum, 1 % L-glutamine, and 1 % penicillin/streptomycin. All cells were maintained in a 33°C, humidified incubator with 5 % CO 2 .
Chemical Preparations
Sodium chromate (Na 2 CrO 4 ) was used as a representative soluble Cr(VI) compound and desired dilutions were made with sterile distilled water as previously described [18] . Lead chromate (PbCrO 4 ) was used as a particulate model for Cr(VI) and particles were suspended in sterile distilled water as previously described [18] .
Cytotoxicity
Cytotoxicity was measured with a clonogenic assay using our published methods [13] . Briefly, cells were seeded as a monolayer in a six-well cell culture plate and allowed to grow for 48 h. Cells were then treated with either sodium or lead chromate at concentrations ranging from 0 to 10 μM of and 1 to 100 μg/cm 2 , respectively, for 24 h. Then the cells were reseeded at colony-forming density and allowed to grow for about 2 weeks. Then the colonies were stained using crystal violet. The colonies were counted and cell survival was calculated relative to the control. Experiments were repeated at least three times.
Genotoxicity
Genotoxicity was measured with a chromosome damage assay using our published methods [13] . Briefly, cells were seeded as a monolayer in 100 mm Petri dishes and allowed to grow for 48 h. Cells were then treated with either sodium or lead chromate at concentrations ranging from 0 to 10 μM and 1 to 10 μg/cm 2 , respectively, for 24 h. Cells were arrested in metaphase using 0.1 μg/ml demecolcine. Then the cells were resuspended in 0.075 M potassium chloride hypotonic solution for 17 min and then fixed in methanol/acetic acid (3:1). Cells were washed twice with fix then dropped onto a microscope slide and stained with 5 % Giemsa stain in Gurr's buffer. One hundred metaphases were scored per concentration for each experiment.
Intracellular Chromium Measurement Intracellular chromium ion levels were measured by inductively coupled plasma atomic emission spectrometry (ICP-AES) using our published methods [16] . A monolayer of cells was treated with various concentrations of sodium chromate and lead chromate for 24 h. The cells were harvested and treated with a hypotonic solution followed by 2 % SDS. This solution was sheered through a needle seven times and filtered into a vial. Chromium ion concentrations of the samples were then measured using standard ICP methods.
Biopsies
Biopsies were collected from healthy free-ranging fin whales in the Gulf of Maine between 2010 and 2012 based on published methods [13] . Sampling efforts were conducted jointly with photo-identifications of individual whales to minimize duplication. Samples were collected with stainless steel cylindrical biopsy tips 6 mm in diameter, with a flared rim and stop collar to limit penetration to the skin and blubber interface. Biopsy tips were attached to an arrow and delivered to the animal via a crossbow with a maximum draw weight of 68 kg (150 lbs). Arrows were retrieved through the use of floatation collars. Tissue samples were removed from the biopsy tip with clean, sterile forceps. The skin was removed and a portion for metal analysis immediately placed in a sterile, labeled tube, and stored frozen at −20°C. We previously demonstrated there is no contamination by the biopsy dart or the forceps [4] .
Tissue Chromium Measurement
Total Cr present in skin biopsies was measured using inductively coupled plasma mass spectroscopy (ICPMS). All samples were analyzed at the Center for Environmental Sciences and Engineering at the University of Connecticut, Storrs [13] . Each sample was frozen and stored at −20°C. Samples were analyzed for chromium using ICPMS. Each sample, between 0.3 and 0.7 g, was rinsed with deionized water, air dried in a laminar flow hood, weighed, placed in a digestion tube with nitric acid, and refluxed for 4 h at 95°C. Each sample was then cooled, and 2 ml deionized water and 3 ml of trace metal grade hydrogen peroxide were added. Each sample was then heated in a hot block until the effervescence subsided. The samples were then cooled and brought to a final volume of 10 ml with deionized water.
Samples were analyzed on a Perkin-Elmer/Sciex ELAN ICPMS using standard protocols. Samples were run undiluted, and when over range, diluted fivefold. Interference check solutions were analyzed (ICS A and ICS A+B; High Purity Standards, Charleston, SC) with all sample runs to compensate for any matrix effects which may interfere with sample analysis. Standard quality assurance procedures were employed. Instrument response was evaluated, every 10 samples and at the end of an analytical run using a calibration verification standard and blank. For the Cr measurements, the analysis of duplicate samples had a relative percent difference of 12.4±3.2 %; the method blanks measured below detection limit (0.08 μg/g); the spiked samples had a 87.8± 3.4 % recovery; laboratory control samples (LCS) had an 100.3±0.6 % recovery; and the standard reference materials (SRM) (DORM-3;NRC Canada) had an 114.6±6.3 % recovery. All quality control parameters, including all standard reference material data, were within method specifications. Data are presented in units of microgram per gram wet weight (w.w.).
Statistics
Responses for individual doses were compared using t tests. LC50's and EC20's were estimated using linear regression analysis, and variances were calculated using the variancecovariance matrix. No adjustment was made for multiple comparison.
Results
Chromium Skin Levels
In organisms and cells, Cr(VI) is rapidly and immediately reduced to Cr(III); thus, it is not technically possible to directly identify which valence of Cr the animal was originally exposed to and measurements are simply made of total Cr in the tissue. We measured the level of total Cr in skin biopsies from nine free-ranging fin whales including six males and three females. All animals appeared to be adult-sized. All nine animals had measureable levels of Cr. Individual Cr levels ranged from 1.71 to 19.6 μg/g with an average level of 10.07 μg/g (Fig. 1) indicating the presence of Cr in the fin whales' environment.
Cytotoxicity of Particulate and Soluble Cr(VI) in Fin Whale Skin Cells
Both particulate and soluble Cr(VI) induced a concentrationdependent increase in cytotoxicity. Concentrations of 0.1, 1.0, 5, 10, and 20 μg/cm 2 lead chromate induced 90, 68, 48, 33, and 24 % relative survival, respectively (Fig. 2) . Concentrations of 1, 2.5, 5, and 10 μM sodium chromate induced 84, 72, 38, and 10 % relative survival, respectively (Fig. 3) . Because the particulate compound (lead chromate) does not fully dissolve in water, but the soluble compound (sodium chromate) does, it is not possible to accurately compare to the data based on administered dose.
In order to compare the two compounds, we measured intracellular Cr ion levels. Both compounds increased the intracellular Cr levels in a concentration-dependent manner (Figs. 4 and 5) . Considering the cytotoxicity data based on intracellular Cr level, Fig. 6 shows soluble chromate is more cytotoxic to fin whale skin cells than particulate chromate. For example, the LC 50 for sodium chromate, based on intracellular concentration, was 390 μM, which is threefold lower than the 1,125 μM LC 50 for lead chromate (p<0.001).
Clastogenicity of Particulate and Soluble Cr(VI) in Fin Whale Skin Cells
The genotoxicity of particulate and soluble Cr(VI) was determined through the production of chromosome aberrations quantified through two measures: (1) the percent of metaphases with damage, which uses the cell as the unit of comparison; and (2) total chromosome damage, which uses the chromosome as the unit of comparison. Both particulate and soluble Cr(VI) induced a concentration-dependent increase in genotoxicity. Lead chromate concentrations of 0, 1, 5, and 10 μg/cm 2 induced aberrations in 4, 20, 25, and 33 % of metaphases and a total of 4, 23, 30, and 46 aberrations in 100 metaphases (Fig. 7) . Sodium chromate concentrations of 0, 1, 2.5, and 5 μM induced aberrations in 2, 9, 14, and 21 % of metaphases and a total of 2, 10, 15, and 23 aberrations in 100 metaphases (Fig. 8) . Considering the data based on intracellular Cr levels, Fig. 9 shows sodium chromate and lead chromate were similarly potent. For example, the EC 20 s for sodium chromate and lead chromate, based on intracellular concentration, were 611 and 820 μM, respectively, for the percent of metaphases with damage, and 507 and 709 μM, respectively, for the total aberrations in 100 metaphases.
Discussion
Cr(VI) is emerging as a global health concern for the marine environment [4] . This study is the first to report metal toxicity in fin whales. The data extend our current knowledge of metal genotoxicity in whales from cells from two whale species, Northern right whales (a baleen whale) and sperm whales (a toothed whale), to add fin whales (a second baleen whale). The data indicate both that fin whales are exposed to Cr and that Cr has the potential for cytotoxic and genotoxic outcomes in this species. The data also suggest there is a marine Cr exposure concern in the Gulf of Maine or along the Eastern seaboard of the USA. Previous data from Northern right whales sampled prior to 2008, off the coast of Maine, revealed a mean total Cr level of 7.1 μg/g w.w. [13] . A similar study of Southern right whales sampled off the coast of Argentina in 2011 reported a mean skin Cr level of 0.64 μg/g wet weight [14] . In this study of fin whales sampled in the Gulf of Maine from 2010 to 2012, we found a mean skin Cr level 1.4 times higher than that of the Northern right whales. Given the geographic overlap of Northern right and fin whale compared to their geographically distinct Southern right whale cousins, the data suggest a significant Cr input in the habitat of the northern two whale species. These high levels are not normal for marine mammals as they exceed levels previously reported [19] [20] [21] [22] , nor are they normal for mammals in general as they are 32 times higher than levels reported for humans without occupational exposure [23] .
Of course, it cannot be directly determined which valence of Cr the whales encountered. This uncertainty arises simply because Cr(VI) is so quickly reduced to Cr(III) in cells and tissues; once reduced, it quickly complexes with intracellular Fig. 3 This figure shows soluble Cr(VI) is cytotoxic to fin whale skin fibroblasts in a concentration-dependent manner. The data represent an average of 3 experiments±standard error of mean. Concentrations of 1-100 μM were significantly different from control (p < 0.02). For comparisons between concentrations: 1 μM was significantly different from and 2.5-100 μM (p<0.001); 2.5 μM was significantly different from 1 and 5-100 μM (p<0.001); 5 μM was significantly different from 1-2.5 and 10-100 μM (p<0.001); 10 μM was significantly different from 1-5 and 25-100 μM (p<0.001); 25 μM was significantly different from 1-10 and 50-100 μM (p<0.001); 50 μM was significantly different from 1-25 and 100 μM (p<0.001) Fig. 4 This figure shows intracellular chromium concentrations in fin whale skin cells increase after lead chromate treatment. Intracellular lead ions area also produced, but do not increase with concentration. The data represent an average of 3 experiments±standard error of mean compounds including amino acids and proteins [24] . However, it can indirectly be inferred that a substantial amount of the exposure most likely included Cr(VI) because Cr(III) is very poorly absorbed in mammalian systems [1] . Substantial amounts of Cr(VI) are released into the environment and Cr(VI) is the major valence of Cr in marine waters [2] ; therefore, given its availability and high level, the data suggest a significant portion of the exposure most likely involved Cr(VI).
The observations that particulate Cr(VI) is cytotoxic in a concentration-dependent manner are consistent with previous data showing lead chromate is cytotoxic to North Atlantic right whale cells [13, 15, 16] . Comparing the two species suggests fin whales are less susceptible to Cr(VI)-induced cell death. For example, 5 μg/cm 2 lead chromate induced 5-fold less cell death in fin whale cells than in North Atlantic right whale skin cells [15] . The explanation for this difference is probably due to differences in lead chromate-induced genotoxicity between the two species.
The observations that particulate Cr(VI) is genotoxic in a concentration-dependent manner is consistent with previous data showing lead chromate is genotoxic to North Atlantic right whale cells [13, 15, 16] . Comparing the two species suggests fin whales are also less susceptible to Cr(VI)-induced is tempting to speculate this difference is due to either Cr(VI) or lead uptake, but we have found fin whale cells take up 2.5-fold more Cr(VI) and 3.3-fold less lead than right whale skin cells (unpublished observations); thus, this does not appear to be the explanation. Instead, it is most likely some undiscovered, species-related difference in the response to either or both of these two metals. Soluble Cr(VI) toxicity has not been reported for a baleen whale skin cell before so such comparisons are not possible. It is interesting to note that when compared on an intracellular level, both Cr(VI) compounds induced a similar amount of genotoxicity, but soluble Cr(VI) was more cytotoxic. This outcome suggests the particulate compound, perhaps through the action of the lead cation, can induce DNA damage, but some damaged cells survive. Such an outcome is consistent with observations in humans and rodents that the particulate Cr(VI) compounds are a greater health concern and the more potent carcinogens [25, 26] . It suggests a similar potency difference exists for whales exposed to airborne Cr(VI) particles.
It is difficult to directly compare cell culture concentrations with tissue levels. The most basic approach is to express all levels in units of parts per million, although this simplified approach ignores important confounding factors. Under this approach, our administered doses of 1, 2.5, 5, and 10 μM sodium chromate convert to 0.052, 0.130, 0.260, and 0.520 ppm total Cr, respectively. For lead chromate, the administered doses of 0.1, 1.0, 5, 10, and 20 μg/cm 2 convert to 0.068, 0.68, 3.4, 6.8, and 13.6 ppm total Cr, respectively. Thus, our treatments ranged from 0.052 to 13.6 ppm. The fin whale skin Cr tissue levels are in microgram per gram, which directly converts to parts per million. Thus, the total Cr levels in fin whale skin range from 1.71 to 19.6 ppm with a mean level of 10.07 ppm. Using this simplified approach, all of our cell culture treatments were lower than the mean Cr tissue levels except for our highest lead chromate treatment. Furthermore, all of them were below the high end of the range, found in the tissue, and several of the lower treatments were 2.5-33-fold lower than the low end of the whale tissue range.
A second approach is to consider the doses based on a hypothetical exposure. In this instance, one can be posited for whale inhalation. Such an exposure is an important route given the large whale lung volumes and their lifestyle Fig. 9 This figure shows sodium chromate and lead chromate exhibit a similar genotoxic response based upon intracellular uptake. The data represent an average of 3-4 experiments±standard error of mean requirements to hold their breaths for lengthy periods of time, which may increase deposition and absorption of inhaled particles [27] . Fin whales lung volume and respiration rate are estimated to be 2 m 3 and 24 breaths/hour, respectively [28] . The fin whales sampled in this study have a range along the Eastern US seaboard. Marine atmospheric chromium levels are not commonly measured, but based on an average marine air level of 0.226 μg/m 3 reported for Baltimore harbor [1] , the fin whales near Baltimore could inhale about 260 μg in 24 h (0.226 μg/m 3 ×2 m 3 /breath×24 breaths/h×24 h=260 μg). If 35 % of this total airborne level was hexavalent as predicted [1] , then a whale would inhale 91 μg Cr(VI) in 24 h. In our studies, we treated for 24 h with 0.88-176 μg Cr(VI). Thus, by this approach our concentrations also model a potential environmental exposure.
In conclusion, our data show that Cr is present in fin whale skin tissue and is cytotoxic and genotoxic to fin whale skin cells. The data further suggest that particulate Cr(VI) is a particular concern with some damaged cells surviving. These data, along with the data from the Northern right whale testes and lung cell cultures, suggest that Cr could be a reproductive or an inhalation hazard for fin whales as well. Altogether, the data support a hypothesis that chromium is a current marine health concern for whales and particularly for the Gulf of Maine. Further studies are needed to elucidate the potential sources and pathways of exposure to chromium to fin whales, and how these may be affecting their health and reproductive success.
